Clinical studies recruiting near Panorama City

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Kaiser Permanente - Panorama City · Alliance for Clinical Trials in Oncology · NCT07321652 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · Eli Lilly and Company · NCT07415044 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kaiser Permanente - Panorama City · NRG Oncology · NCT05174169 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Kaiser Permanente - Panorama City · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Kaiser Permanente - Panorama City · Canadian Cancer Trials Group · NCT06592924 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Kaiser Permanente - Panorama City · NRG Oncology · NCT06748222 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Kaiser Permanente - Panorama City · National Cancer Institute (NCI) · NCT05256225 Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
NA · Kaiser Permanente - Panorama City · NRG Oncology · NCT05080673 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Kaiser Permanente - Panorama City · National Cancer Institute (NCI) · NCT05987241 Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Phase 2 · Kaiser Permanente - Panorama City · SWOG Cancer Research Network · NCT04205968 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Kaiser Permanente - Panorama City · SWOG Cancer Research Network · NCT06616584 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · Kaiser Permanente - Panorama City · SWOG Cancer Research Network · NCT03723928 Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-sm
Phase 3 · Daiichi Sankyo · NCT06899126 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Kaiser Permanente - Panorama City · National Cancer Institute (NCI) · NCT04267848 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Kaiser Permanente - Panorama City · SWOG Cancer Research Network · NCT03851445 Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance C
Phase 3 · Kaiser Permanente - Panorama City · National Cancer Institute (NCI) · NCT07061977 A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NA · Kaiser Permanente - Panorama City · NRG Oncology · NCT04251052 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · Kaiser Permanente - Panorama City · NRG Oncology · NCT06580314 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A L
Phase 2 · Kaiser Permanente - Panorama City · SWOG Cancer Research Network · NCT05642572 Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cel
Phase 3 · Gilead Sciences · NCT06801834 A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colo
Phase 3 · Kaiser Permanente Panorama City Medical Center · Seagen, a wholly owned subsidiary of Pfizer · NCT05253651 Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung
Phase 2 · Kaiser Permanente - Panorama City · SWOG Cancer Research Network · NCT06031688 Zimmer Biomet Shoulder Arthroplasty PMCF
NA · Zimmer Biomet · NCT04984291 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal
Phase 3 · Kaiser Permanente - Panorama City · NRG Oncology · NCT05879926 A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Phase 2 · Kaiser Permanente Panorama City Medical Center, Medical Offi · Seagen, a wholly owned subsidiary of Pfizer · NCT04879329 A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With
Phase 2 · AbbVie · NCT06820463 Mobile Health for Adherence in Breast Cancer Patients
NA · Kaiser Permanente - Panorama City · ECOG-ACRIN Cancer Research Group · NCT06112613 Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Phase 3 · Kaiser Permanente - Panorama City · SWOG Cancer Research Network · NCT05929768 Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Phase 2/Phase 3 · Kaiser Permanente - Panorama City · National Cancer Institute (NCI) · NCT06203600 A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Di
Phase 3 · Merck Sharp & Dohme LLC · NCT06430801

Look up another city

Look up another condition